Business Description
Thomson Medical Group Ltd
ISIN : SG1M49904634
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 2.24 | |||||
Debt-to-EBITDA | 10.23 | |||||
Interest Coverage | 0.95 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.1 | |||||
Beneish M-Score | -2.9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13 | |||||
3-Year EBITDA Growth Rate | 10.1 | |||||
3-Year FCF Growth Rate | 26 | |||||
Future 3-5Y Total Revenue Growth Rate | 8.15 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.54 | |||||
9-Day RSI | 45.83 | |||||
14-Day RSI | 46.42 | |||||
6-1 Month Momentum % | -4 | |||||
12-1 Month Momentum % | -17.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.08 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.57 | |||||
Days Inventory | 472.45 | |||||
Days Sales Outstanding | 39.29 | |||||
Days Payable | 337.98 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -28.26 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.58 | |||||
Operating Margin % | 13.92 | |||||
Net Margin % | 4.4 | |||||
FCF Margin % | 15.09 | |||||
ROE % | 3.11 | |||||
ROA % | 0.9 | |||||
ROIC % | 2.11 | |||||
ROC (Joel Greenblatt) % | 16.76 | |||||
ROCE % | 5.56 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 47 | |||||
Forward PE Ratio | 47 | |||||
PE Ratio without NRI | 47 | |||||
Price-to-Owner-Earnings | 48 | |||||
PEG Ratio | 2.6 | |||||
PS Ratio | 3.61 | |||||
PB Ratio | 2.48 | |||||
Price-to-Free-Cash-Flow | 23.5 | |||||
Price-to-Operating-Cash-Flow | 15.67 | |||||
EV-to-EBIT | 27.68 | |||||
EV-to-Forward-EBIT | 25.11 | |||||
EV-to-EBITDA | 20.74 | |||||
EV-to-Forward-EBITDA | 18.31 | |||||
EV-to-Revenue | 6.47 | |||||
EV-to-Forward-Revenue | 5.3 | |||||
EV-to-FCF | 41.96 | |||||
Price-to-Projected-FCF | 1.57 | |||||
Earnings Yield (Greenblatt) % | 3.62 | |||||
FCF Yield % | 4.27 | |||||
Forward Rate of Return (Yacktman) % | 21.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Thomson Medical Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil S$) | 351.154 | ||
EPS (TTM) (S$) | 0.001 | ||
Beta | 0.69 | ||
Volatility % | 18.69 | ||
14-Day RSI | 46.42 | ||
14-Day ATR (S$) | 0.001042 | ||
20-Day SMA (S$) | 0.04735 | ||
12-1 Month Momentum % | -17.24 | ||
52-Week Range (S$) | 0.046 - 0.062 | ||
Shares Outstanding (Mil) | 26,441.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Thomson Medical Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Thomson Medical Group Ltd Stock Events
Event | Date | Price(S$) | ||
---|---|---|---|---|
No Event Data |
Thomson Medical Group Ltd Frequently Asked Questions
What is Thomson Medical Group Ltd(SGX:A50)'s stock price today?
When is next earnings date of Thomson Medical Group Ltd(SGX:A50)?
Does Thomson Medical Group Ltd(SGX:A50) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |